Seema Sheoran

Stock Analyst at Rodman & Renshaw

(1.76)

# 3,392

Out of 5,240 analysts

3

Total ratings

66.67%

Success rate

1.6%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Seema Sheoran

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	SABS SAB Biotherapeutics	Reiterates: Buy	$13	$3.96	+228.28%	2	May 11, 2026
	CAMP Camp4 Therapeutics	Initiates: Buy	$7	$4.50	+55.56%	1	Apr 14, 2026

SAB Biotherapeutics

May 11, 2026

Reiterates: Buy

Price Target: $13

Current: $3.96

Upside: +228.28%

Camp4 Therapeutics

Apr 14, 2026

Initiates: Buy

Price Target: $7

Current: $4.50

Upside: +55.56%